by Kimberly Waller | Jun 12, 2026
Kerrie-Anne Ho, PhD, Patient Preference Lead at UCB, discusses preferences and perceptions of acute seizure medications. Data from interviews with people with seizures (PwS) and caregiver interviews were presented at the American Academy of Neurology (AAN) 2026...
by Kimberly Waller | May 26, 2026
Mauro Cives, MD, Associate Professor of Medical Oncology at the University of Bari, Italy, discusses the upcoming regulatory decision for LNTH-2501 to improve imaging of neuroendocrine tumors (NETs). NETs are rare tumors that usually develop in the...
by Kimberly Waller | May 7, 2026
Colin Lake, Head of Digital Business Transformation Neurology at UCB, discusses CareCompass, an online tool for caregivers of patients with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS). DS is the most severe of a group of conditions known as...
by Kimberly Waller | May 1, 2026
A study published in the Annals of the American Thoracic Society analyzed results from the ELEVATE-1 clinical trial testing the effects of rodatristat ethyl on daily activity in patients with pulmonary arterial hypertension (PAH). PAH is a rare condition affecting the...
by Kimberly Waller | Apr 20, 2026
Prem Subramanian, MD, PhD, Chief of Neuro-Ophthalmology at the University of Colorado Anschutz, discusses Tepezza (teprotumumab-trbw) for the treatment of thyroid eye disease (TED). TED is a chronic endocrine, autoimmune disease characterized by...
